When the patent for aspirin was obtained... it was created by Hoffman working at Bayer company
On March 6, 1899, Bayer Company patented aspirin, a drug derived from a chemical found in willow tree bark.
On March 6, 1899, the German company Bayer patented aspirin, a common household medication known scientifically as acetylsalicylic acid. This compound, originally derived from a chemical found in the bark of willow trees, has a long history of use in traditional medicine, dating back to ancient Greece, where it was employed as a remedy for pain and fever. Although physicians were aware of its medicinal properties by the mid-19th century, its unpleasant taste and tendency to upset the stomach limited its usage.
The breakthrough came in 1897 when Felix Hoffmann, a Bayer employee, developed a more stable and palatable form of the drug, making it easier for patients to consume. However, historical accounts suggest that a Jewish chemist named Arthur Eichengrün may have played a significant role in this development, a contribution that was downplayed during the Nazi era. Once Bayer secured the patent, they began distributing aspirin in powder form to physicians, allowing them to administer a one-gram dose to patients effectively.
The brand name reached wider audiences and has since become synonymous with pain relief. Aspirin's journey from a natural remedy used in ancient civilizations to a staple in modern medicine highlights its significance and the controversies surrounding its discovery and commercialization. Today, it continues to be one of the most widely used drugs across the globe, reflecting the important historical and scientific milestones in its development.